<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32043633</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-2272</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Genetic epidemiology</Title><ISOAbbreviation>Genet Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Incorporating external information to improve sparse signal detection in rare-variant gene-set-based analyses.</ArticleTitle><Pagination><StartPage>330</StartPage><EndPage>338</EndPage><MedlinePgn>330-338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/gepi.22283</ELocationID><Abstract><AbstractText>Gene-set analyses are used to assess whether there is any evidence of association with disease among a set of biologically related genes. Such an analysis typically treats all genes within the sets similarly, even though there is substantial, external, information concerning the likely importance of each gene within each set. For example, for traits that are under purifying selection, we would expect genes showing extensive genic constraint to be more likely to be trait associated than unconstrained genes. Here we improve gene-set analyses by incorporating such external information into a higher-criticism-based signal detection analysis. We show that when this external information is predictive of whether a gene is associated with disease, our approach can lead to a significant increase in power. Further, our approach is particularly powerful when the signal is sparse, that is when only a small number of genes within the set are associated with the trait. We illustrate our approach with a gene-set analysis of amyotrophic lateral sclerosis (ALS) and implicate a number of gene-sets containing SOD1 and NEK1 as well as showing enrichment of small p values for gene-sets containing known ALS genes. We implement our approach in the R package wHC.</AbstractText><CopyrightInformation>&#xa9; 2020 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Mengqi</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1091-1014</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Genomic and Computational Biology, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Statistical Genetics and Genomics, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelfman</LastName><ForeName>Sahar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Genomic Medicine, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarthy</LastName><ForeName>Janice</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harms</LastName><ForeName>Matthew B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Institute of Genomic Medicine, Columbia University, New York City, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Columbia University, New York City, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Disease, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Cristiane A M</ForeName><Initials>CAM</Initials><Identifier Source="ORCID">0000-0002-5867-6359</Identifier><AffiliationInfo><Affiliation>Institute of Genomic Medicine, Columbia University, New York City, New York.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Motor Neuron Biology and Disease, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>David B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Institute of Genomic Medicine, Columbia University, New York City, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Andrew S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0002-7232-2143</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Genomic and Computational Biology, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Statistical Genetics and Genomics, Duke University, Durham, North Carolina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Genet Epidemiol</MedlineTA><NlmUniqueID>8411723</NlmUniqueID><ISSNLinking>0741-0395</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C000606914">NEK1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000072380">NIMA-Related Kinase 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059472" MajorTopicYN="N">Exome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072380" MajorTopicYN="N">NIMA-Related Kinase 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014584" MajorTopicYN="N">User-Computer Interface</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">gene-set-based analysis</Keyword><Keyword MajorTopicYN="N">higher criticism</Keyword><Keyword MajorTopicYN="N">prior information</Keyword><Keyword MajorTopicYN="N">weighted p values</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32043633</ArticleId><ArticleId IdType="doi">10.1002/gepi.22283</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>ALS Data Browser, Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. A., &#x2026; Goldstein, D. B. (2015). ALSdb, v3. Retrieved from http://alsdb.org [dataset].</Citation></Reference><Reference><Citation>Barab&#xe1;si, A.-L., &amp; Albert, R. (1999). Emergence of scaling in random networks. Science, 286(5439), 509-512. https://doi.org/10.1126/science.286.5439.509</Citation></Reference><Reference><Citation>Barnett, I. J., &amp; Lin, X. (2014). Analytic p-value calculation for the higher criticism test in finite d problems. Biometrika, 101(4), 964-970. https://doi.org/10.1093/biomet/asu033</Citation></Reference><Reference><Citation>Basu, S., &amp; Pan, W. (2011). Comparison of statistical tests for disease association with rare variants. Genetic Epidemiology, 35(7), 606-619. https://doi.org/10.1002/gepi.20609</Citation></Reference><Reference><Citation>Biological General Repository for Interaction Datasets, Stark, C, Breitkreutz, BJ, Reguly, T, Boucher, L, Breitkreutz, A, &amp; Tyers, M. (2006). BioGRID3.4, v3.4.153. Retrieved from https://downloads.thebiogrid.org/BioGRID [dataset].</Citation></Reference><Reference><Citation>Borgatti, S. P. (2005). Centrality and network flow. Social Networks, 27(1), 55-71. https://doi.org/10.1016/j.socnet.2004.11.008</Citation></Reference><Reference><Citation>Chatr-Aryamontri, A., Oughtred, R., Boucher, L., Rust, J., Chang, C., Kolas, N. K., &#x2026; Tyers, M. (2017). The BioGRID interaction database: 2017 update. Nucleic Acids Research, 45(Database issue), D369-D379. https://doi.org/10.1093/nar/gkw1102</Citation></Reference><Reference><Citation>Cirulli, E. T., Lasseigne, B. N., Petrovski, S., Sapp, P. C., Dion, P. A., Leblond, C. S., &#x2026; Goldstein, D. B. (2015). Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science, 347(6229), 1436-1441. https://doi.org/10.1126/science.aaa3650</Citation></Reference><Reference><Citation>Donoho, D., &amp; Jin, J. (2004). Higher criticism for detecting sparse heterogeneous mixtures. The Annals of Statistics, 32(3), 962-994.</Citation></Reference><Reference><Citation>Epstein, M. P., Allen, A. S., &amp; Satten, G. A. (2007). A simple and improved correction for population stratification in case-control studies. The American Journal of Human Genetics, 80(5), 921-930. https://doi.org/10.1086/516842</Citation></Reference><Reference><Citation>Freeman, L. C., Roeder, D., &amp; Mulholland, R. R. (1979). Centrality in social networks: II. Experimental results. Social Networks, 2(2), 119-141. https://doi.org/10.1016/0378-8733(79)90002-9</Citation></Reference><Reference><Citation>Ge, Y., Dudoit, S., &amp; Speed, T. P. (2003). Resampling-based multiple testing for microarray data analysis. Test, 12(1), 1-77. https://doi.org/10.1007/BF02595811</Citation></Reference><Reference><Citation>Gelfman, S., Dugger, S. A., Moreno, C. A. M., Ren, Z., Wolock, C. J., Shneider, N. A., &#x2026; Goldstein, D. B. (2018). Regional collapsing of rare variation implicates specific genic regions in ALS. BioRxiv, 375774. https://doi.org/10.1101/375774</Citation></Reference><Reference><Citation>Genic Intolerance.,&#xa0;Slav&#xe9; Petrovski et al. (2015). v3. Retreived from http://genic-intolerance.org [dataset].</Citation></Reference><Reference><Citation>Genotype-Tissue Expression. (2015).&#xa0;GTEx Consortium, GTEx Portal, v7. Retrieved from https://gtexportal.org/home/datasets [dataset].</Citation></Reference><Reference><Citation>Genovese, C. R., Roeder, K., &amp; Wasserman, L. (2006). False discovery control with p-value weighting. Biometrika, 93(3), 509-524.</Citation></Reference><Reference><Citation>Goh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M., &amp; Barab&#xe1;si, A.-L. (2007). The human disease network. Proceedings of the National Academy of Sciences of the United States of America, 104(21), 8685-8690.</Citation></Reference><Reference><Citation>GTEx Consortium. (2015). The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Science, 348(6235), 648-660.</Citation></Reference><Reference><Citation>Han, F., &amp; Pan, W. (2010). A data-adaptive sum test for disease association with multiple common or rare variants. Human Heredity, 70(1), 42-54. https://doi.org/10.1159/000288704</Citation></Reference><Reference><Citation>Jaeschke, D. (1979). The asymptotic distribution of the supremum of the standardized empirical distribution function on subintervals. Ann. Statist, 7(1), 108-115.</Citation></Reference><Reference><Citation>Lee, S., Wu, M. C., &amp; Lin, X. (2012). Optimal tests for rare variant effects in sequencing association studies. Biostatistics, 13(4), 762-775. https://doi.org/10.1093/biostatistics/kxs014</Citation></Reference><Reference><Citation>Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., &amp; Fennell, T., &#x2026; Exome Aggregation Consortium. (2016). Analysis of protein-coding genetic variation in 60,706 humans. Nature, 536(7616), 285-291. https://doi.org/10.1038/nature19057</Citation></Reference><Reference><Citation>Liberzon, A., Birger, C., Thorvaldsd&#xf3;ttir, H., Ghandi, M., Mesirov, J. P., &amp; Tamayo, P. (2015). The molecular signatures database hallmark gene set collection. Cell Systems, 1(6), 417-425. https://doi.org/10.1016/j.cels.2015.12.004</Citation></Reference><Reference><Citation>Ma, Y., &amp; Wei, P. (2019). FunSPU: A versatile and adaptive multiple functional annotation-based association test of whole-genome sequencing data. PLOS Genetics, 15(4):e1008081. https://doi.org/10.1371/journal.pgen.1008081</Citation></Reference><Reference><Citation>Madsen, B. E., &amp; Browning, S. R. (2009). A groupwise association test for rare mutations using a weighted sum statistic. PLOS Genetics, 5(2):e1000384. https://doi.org/10.1371/journal.pgen.1000384</Citation></Reference><Reference><Citation>Molecular Signatures Database, Subramanian, Tamayo, et al. (2018).&#xa0;MSigDB, v6.1. Retreived from http://software.broadinstitute.org/gsea/msigdb/ [dataset].</Citation></Reference><Reference><Citation>Neale, B. M., Rivas, M. A., Voight, B. F., Altshuler, D., Devlin, B., Orho-Melander, M., &#x2026; Daly, M. J. (2011). Testing for an Unusual Distribution of Rare Variants. PLOS Genetics, 7(3):e1001322. https://doi.org/10.1371/journal.pgen.1001322</Citation></Reference><Reference><Citation>OMIM. (n.d.). Online Mendelian inheritance in man. Retrieved from https://www.omim.org/</Citation></Reference><Reference><Citation>Page, L., Brin, S., Motwani, R., &amp; Winograd, T. (1999). The PageRank citation ranking: Bringing order to the web. Retrieved from http://ilpubs.stanford.edu:8090/422</Citation></Reference><Reference><Citation>Palmer, S. M., Snyder, L., Todd, J. L., Soule, B., Christian, R., Anstrom, K., &#x2026; Rosen, G. (2018). Randomized, double-blind, placebo-controlled, phase 2 trial of BMS-986020, a lysophosphatidic acid receptor antagonist for the treatment of idiopathic pulmonary fibrosis. Chest, 154(5), 1061-1069. https://doi.org/10.1016/j.chest.2018.08.1058</Citation></Reference><Reference><Citation>Pan, W., Kwak, I.-Y., &amp; Wei, P. (2015). A powerful pathway-based adaptive test for genetic association with common or rare variants. American Journal of Human Genetics, 97(1), 86-98. https://doi.org/10.1016/j.ajhg.2015.05.018</Citation></Reference><Reference><Citation>Petrovski, S., Wang, Q., Heinzen, E. L., Allen, A. S., &amp; Goldstein, D. B. (2013). Genic intolerance to functional variation and the interpretation of personal genomes. PLOS Genetics, 9(8):e1003709. https://doi.org/10.1371/journal.pgen.1003709</Citation></Reference><Reference><Citation>Poppe, L., Ru&#xe9;, L., Robberecht, W., &amp; Van Den Bosch, L. (2014). Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS). Experimental Neurology, 262, 138-151. https://doi.org/10.1016/j.expneurol.2014.07.001</Citation></Reference><Reference><Citation>Roeder, K., &amp; Wasserman, L. (2009). Genome-Wide Significance Levels and Weighted Hypothesis Testing. Statistical Science: A Review Journal of the Institute of Mathematical Statistics, 24(4), 398-413. https://doi.org/10.1214/09-STS289</Citation></Reference><Reference><Citation>Stark, C., Breitkreutz, B.-J., Reguly, T., Boucher, L., Breitkreutz, A., &amp; Tyers, M. (2006). BioGRID: A general repository for interaction datasets. Nucleic Acids Research, 34(Database issue), D535-D539. https://doi.org/10.1093/nar/gkj109</Citation></Reference><Reference><Citation>Stephenson, K., &amp; Zelen, M. (1989). Rethinking centrality: Methods and examples. Social Networks, 11(1), 1-37. https://doi.org/10.1016/0378-8733(89)90016-6</Citation></Reference><Reference><Citation>Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., &#x2026; Mesirov, J. P. (2005). Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America, 102(43), 15545-15550. https://doi.org/10.1073/pnas.0506580102</Citation></Reference><Reference><Citation>Wasserman, S., &amp; Faust, K. (1994). Social network analysis: Methods and applications. Cambridge: Cambridge University Press.</Citation></Reference><Reference><Citation>White, S., &amp; Smyth, P. (2003). Algorithms for estimating relative importance in networks. Proceedings of the Ninth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, pp. 266-275. https://doi.org/10.1145/956750.956782</Citation></Reference><Reference><Citation>Wu, C., &amp; Pan, W. (2018). Integrating eQTL data with GWAS summary statistics in pathway-based analysis with application to schizophrenia. Genetic Epidemiology, 42(3), 303-316. https://doi.org/10.1002/gepi.22110</Citation></Reference><Reference><Citation>Wu, M. C., Lee, S., Cai, T., Li, Y., Boehnke, M., &amp; Lin, X. (2011). Rare-variant association testing for sequencing data with the sequence kernel association test. The American Journal of Human Genetics, 89(1), 82-93. https://doi.org/10.1016/j.ajhg.2011.05.029</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>